Clinical Trial Update: The KHENEREXT Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KHNEREXT study investigating a treatment for mitochondrial diseases, including the m.3243A>G mutation-related conditions; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maternally Inherited Diabetes and Deafness
• Mitochondrial Diseases
• Mitochondrial Dna Trnaleu 3243a Mutation
• Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke Like Episodes
• Progressive External Ophthalmoplegia

Snippet

Sponsor: Khondrion BV | Conditions: Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation | Phase 2 | Status: COMPLETED